A celebrated Australian cancer researcher who transformed himself into a test subject for experimental treatment has passed away at age 59, leaving behind a legacy that revolutionized how doctors treat melanoma.
Richard Scolyer died Sunday night after battling glioblastoma, an aggressive form of brain cancer, according to Australian media reports.
The pathologist and co-medical director of Melanoma Institute Australia received the honor of joint 2024 Australian of the Year alongside his longtime research partner Georgina Long. Their groundbreaking work in immunotherapy transformed advanced melanoma from a death sentence into a manageable condition for countless patients.
After receiving his glioblastoma diagnosis in 2023, Scolyer volunteered for an unprecedented treatment approach that adapted melanoma therapy techniques to target his brain tumor. Long and her research team developed the innovative treatment, which involved using immunotherapy prior to surgical intervention to trigger the body’s immune system to attack the cancer. This groundbreaking approach has since launched a clinical trial in the United States earlier this year.
Throughout his illness, Scolyer maintained a public presence, documenting his journey to shed light on the challenges faced by cancer patients and their families while encouraging continued research innovation. In a posthumous letter, he shared his motivation for transparency during his battle.
“Having dedicated my 35-year working life to patient care, cancer research and improving lives, I wanted to keep contributing, even in my darkest hour,” he wrote.
Prime Minister Anthony Albanese mourned the loss, describing Australia as having lost “one of our brightest lights and one of our biggest hearts.”
“Every day, this remarkable man – the cancer specialist who became his own subject – took us into his confidence, and he lifted us all in the process,” Albanese posted on X, characterizing Scolyer’s public battle as “an act of profound generosity.”
The Prime Minister noted that a newly created Richard Scolyer Chair at Sydney cancer centre Chris O’Brien Lifehouse will honor his memory, stating: “One day when a cure is found, Richard’s name will be spoken.”
Scolyer leaves behind his wife, Dr Katie Nicholl, and three children: Emily, Matthew and Lucy.
